Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q4 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• UBS Starts Capricorn Metals Ltd (CMM:AU) at Buy
• Berenberg Upgrades Bellway Plc. (BWY:LN) to Buy